Clinical Decision-making on Psychopharmacology Prescription
Dieser Vortrag ist nur für Mitglieder der Institution Medical Experts verfügbar.
Du bist nicht eingeloggt. Du musst dich anmelden oder registrieren und Mitglied dieser Institution werden um Zugang zu erhalten. In unserer Hilfe findest du Informationen wie du Mitglied einer Institution werden kannst.
Über den Vortrag
Der Vortrag „Clinical Decision-making on Psychopharmacology Prescription“ von Melissa Kalensky, FNP-BC, PMHNP-BC, CNE ist Bestandteil des Kurses „Psychopharmacology (APRN)“.
Quiz zum Vortrag
What is the initial step in the evidence-based framework for selecting a psychotropic medication?
- Establishing the correct diagnosis using DSM-5-TR guidelines.
- Prioritizing the most cost-effective medication option available.
- Determining the patient's personal medication preference first.
- Choosing the most commonly prescribed drug for the condition.
- Focusing solely on the patient's most prominent symptoms.
When choosing between medications within the same drug category that have similar efficacy, what is the most appropriate approach?
- Prioritize the patient's most bothersome symptom for targeting.
- Select the medication with the most favorable side effect profile.
- Prescribe the drug with the shortest possible half-life duration.
- Choose the least expensive medication option from the category.
- Default to the standard first-line medication for the condition.
When counseling a patient on an SSRI who reports anorgasmia, how should this common side effect be characterized?
- As a persistent effect, lasting as long as the medication is taken.
- As a transient effect, resolving within the first two weeks of use.
- As an effect manageable by reducing the medication's current dosage.
- As an uncommon effect, rarely occurring with this class of medication.
- As an effect that improves on its own with continued medication use.
How should a black box warning, such as increased suicidality risk with SSRIs in younger patients, be interpreted in clinical practice?
- As a serious risk requiring careful monitoring and patient education.
- As an absolute contraindication preventing the use of the medication.
- As a recommendation to always select an alternative medication first.
- As a legal formality to be documented without further discussion.
- As a minor risk factor, relevant only for patients with a history.
Which characteristic of a psychotropic medication is most beneficial for a patient who often forgets to take their doses?
- Its extended half-life, which provides a buffer for missed doses.
- Its rapid onset of action, which offers immediate symptom control.
- Its minimal side-effect profile, which enhances patient comfort.
- Its low potential for interactions, which simplifies other treatments.
- Its availability as a generic, which improves access and lowers cost.
Diese Kurse könnten Sie interessieren
Dozent des Vortrages Clinical Decision-making on Psychopharmacology Prescription
Melissa Kalensky, FNP-BC, PMHNP-BC, CNE
Dr. Melissa Kalensky, FNP-BC, PMHNP-BC, CNE is dual-certified as a Family Nurse Practitioner and a Psychiatric Mental Health Nurse Practitioner.
She specializes in primary care, community health, and integrated behavioral healthcare. Her expertise spans trauma-informed care and psychiatry across all age groups, from children to adults.
At Lecturio, she teaches psychopharmacology to advanced practice providers, helping to bridge the gap between psychiatric and primary care practice.
Kundenrezensionen
5,0 von 5 Sternen
| 5 Sterne |
|
5 |
| 4 Sterne |
|
0 |
| 3 Sterne |
|
0 |
| 2 Sterne |
|
0 |
| 1 Stern |
|
0 |
